Bottles, over the years have emerged as a
preliminary requirement during the course of consumer’s daily lives.
Bottle manufacturers are determined to launch novel product designs that
serve consumer demands as well as preferences. Largely manufactured
from plastic or glass, the cylindrical round bottles largely used as a
dose packaging product for medicinal drugs. Additionally, increased
application of cylindrical round bottles across cosmetics and personal care industry are expected to escalate the growth in the cylindrical round bottle market.
Global Cylindrical Round Bottles Market: Dynamics
Over the coming years, impressive growth
in pharmaceutical industry is composed to replicate significant demand
for cylindrical round bottles. In addition to pharmaceutical industry, a
chunk of demand has been reported from food & beverage ingredients,
cosmetic and other markets.
Nevertheless, the fragile nature as well
as limited recyclable usage of the cylindrical round bottles look to be
the restraining factors for cylindrical round bottles market.
Global Cylindrical Round Bottles Market: Company Developments and Industry Level Trends
Key market participants that operate in
the cylindrical round bottles market have focus towards advances in
terms of bottles design as well as manufacturing capacity expansion all
across the globe.
- In 2014, SIGG Switzerland AG started producing 100% recyclable and BPA free Polypropylene bottles with same ecological standards of aluminum bottles.
- In Oct 2016, Contigo extended its Ashland water bottle design to new glass bottle. The bottle design is also offered in stainless steel and Tritan versions.
Request a PDF Brochure With Future Analysis@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=54132
The global cylindrical round bottles
market is segmented into seven regions, namely, Latin America, North
America, Eastern Europe, Western Europe, Middle East and Africa (MEA),
Asia Pacific Excluding Japan (APEJ), and Japan.
The market for cylindrical round bottles
is largely developed in the Asia-Pacific excluding Japan (APEJ) region
with high pharmaceutical & chemical production over the past decade,
with the some big established enterprises primarily concerted in the
China, India, Thailand, etc.
0 comments:
Post a Comment